We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Inspection Flap Prompts Alexion Risk Assessment Reform
FDA Inspection Flap Prompts Alexion Risk Assessment Reform
May 6, 2013
Alexion is reviewing its analytical methodologies and procedures to ensure its risk assessments meet the FDA’s expectations, the drugmaker said Monday.